The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical products, authorized, on 16
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA) authorized marketing of its Zyn nicotine pouch products, lifting retail sentiment.
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday morning. It is up 28% over the past 12 months.
The Associated Press - Business News on MSN12d
FDA Authorizes Zyn Nicotine Pouches
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes. The Food and Drug Administration OK'd 10 Zyn ...
On January 16, Philip Morris International Inc. (NYSE:PM) announced that the US Food and Drug Administration (FDA) has authorized all ZYN nicotine pouches currently marketed by Swedish Match.
The U.S. Food and Drug Administration has authorized all ZYN Nicotine Pouch Products Currently Marketed by Swedish Match, a
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40 ...